This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Benebiosis Co., Ltd., Korea Research Institute of Bioscience and Biotechnology. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 336 
Years Active: 2012-2013
Title: Cheorl-Ho Kim: Innovator in Eye Disease Treatment and Glycoprotein Analysis
Introduction
Cheorl-Ho Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the fields of ophthalmology and glycoprotein analysis. With a total of 2 patents, his work focuses on innovative solutions for eye diseases and methods for analyzing glycosylation changes in glycoproteins.
Latest Patents
One of his latest patents is a composition for the prevention or treatment of eye diseases. This composition includes a compound that inhibits the expression of MMP-9 and inflammation-mediated cytokines in corneal epithelial cells. It also inhibits VEGF-mediated VEGFR-2 activation in human retinal endothelial cells, demonstrating therapeutic activity for conditions such as dry eye syndrome and inflammatory eye diseases. Importantly, this composition is non-cytotoxic and can be safely used in pharmaceutical, nutraceutical, or food compositions. Additionally, it can serve as a cleaner or lubricant for contact lenses due to its nonbacterial anti-inflammatory activity.
Another significant patent by Cheorl-Ho Kim involves an identification method of glycoproteins using specific lectin precipitation. This method analyzes changes in glycosylation in various glycoproteins that are involved in tumorigenesis and metastasis.
Career Highlights
Throughout his career, Cheorl-Ho Kim has worked with notable companies such as Benebiosis Co., Ltd. and the Korea Research Institute of Bioscience and Biotechnology. His work has contributed to advancements in both biotechnology and medical treatments.
Collaborations
He has collaborated with professionals like Hyang-Sook Yoo and Jong-Shin Yoo, further enhancing the impact of his research and innovations.
Conclusion
Cheorl-Ho Kim's contributions to the treatment of eye diseases and glycoprotein analysis highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile